Reference‐based sensitivity analysis for time‐to‐event data-Reference-Cited by-同舟云学术

Reference‐based sensitivity analysis for time‐to‐event data

Published:2019-07-15 Issue:6 Volume:18 Page:645-658
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

Atkinson Andrew¹²^ORCID,Kenward Michael G.³,Clayton Tim¹,Carpenter James R.¹⁴

Affiliation:

1. Department of Medical StatisticsLondon School of Hygiene and Tropical Medicine London UK

2. Department of Infectious DiseasesBern University Hospital University of Bern, Bern Switzerland

3. Ashkirk Scotland UK

4. MRC Clinical Trials Unit, University College London London UK

Funder

Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.1954

Reference54 articles.

1. Panel on Handling Missing Data in Clinical Trials, Committee on National Statistics, Division of Behavioral and Social Sciences and Education;United States National Research Council,2010

2. CHMP.Guidelines on missing data in confirmatory clinical trials. European Medicines Agency download fromhttp://www.ema.europa.eu accessed 15 January 2014.

3. CHMP.Ich e9 (r1) addendum on estimands and sensitvity analysis in clinical trials to the guidance on statistical principles for clinical trials. European Medicines Agency download fromhttp://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2017/08/WC500233916.pdf

4. Adjusting for Nonignorable Drop-Out Using Semiparametric Nonresponse Models

5. Inference in Randomized Studies with Informative Censoring and Discrete Time-to-Event Endpoints

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Handling Partially Observed Trial Data After Treatment Withdrawal: Introducing Retrieved Dropout Reference‐Base Centred Multiple Imputation;Pharmaceutical Statistics;2024-07-16

2. [Special issue PRO] A demonstration of estimands and sensitivity analyses for time-to-deterioration of patient reported outcomes;Journal of Biopharmaceutical Statistics;2024-04-30

3. Time‐to‐event estimands and loss to follow‐up in oncology in light of the estimands guidance;Pharmaceutical Statistics;2024-03-29

4. Sequential linear regression for conditional mean imputation of longitudinal continuous outcomes under reference-based assumptions;Computational Statistics;2023-12-03

5. An illness–death multistate model to implement delta adjustment and reference‐based imputation with time‐to‐event endpoints;Pharmaceutical Statistics;2023-11-08